The specific Piezo1 inhibitor GsMTx4 has demonstrated preliminary efficacy in preclinical studies, where it suppresses the self‐renewal capacity of cancer stem cells and induces apoptosis by blocking Piezo1‐mediated calcium signaling, ultimately prolonging survival in murine models [52]. The gene discussed is PIEZO1; the disease is cancer.